ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS, MYFORTIC): LONG TERM ADMINISTRATION IS SAFE IN KIDNEY TRANSPLANT PATIENTS

被引：0
|
作者：
Salvadori, Maurizio [1 ]
机构：
[1] Careggi Univ Hosp, Renal Unit, Florence, Italy
来源：
NEPHROLOGY | 2005年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A213 / A214
页数：2
相关论文
共 50 条
  • [1] Long-term administration of enteric-coated mycophenolate sodium (EC-MPS; myfortic®) is safe in kidney transplant patients
    Salvadori, M.
    Holzer, H.
    Civati, G.
    Sollinger, H.
    Lien, B.
    Tomlanovich, S.
    Bertoni, E.
    Seifu, Y.
    Marrast, A. -C.
    [J]. CLINICAL NEPHROLOGY, 2006, 66 (02) : 112 - 119
  • [2] USE OF ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) IN LIVER TRANSPLANT PATIENTS
    de Vera, Michael E.
    Lopez, Roberto
    Yelochan, Barbara
    Hope, Laurie
    Marcos, Amadeo
    Fontes, Paulo
    [J]. LIVER TRANSPLANTATION, 2008, 14 (07) : S112 - S112
  • [3] Mycophenolic acid metabolite profile in renal transplant patients receiving enteric-coated mycophenolate sodium (EC-MPS, Myfortic®).
    Tedesco-Silva, H
    Bastien, MC
    Choi, L
    Felipe, C
    Campestrini, J
    Picard, F
    Schmouder, R
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 250 - 250
  • [4] LONG-TERM SAFETY OF ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) IN RENAL TRANSPLANT RECIPIENTS
    Neumayer, Hans H.
    [J]. NEPHROLOGY, 2005, 10 : A213 - A213
  • [5] Pharmacokinetics (PK) of enteric-coated mycophenolate sodium (EC-MPS, Myfortic®) in stable renal transplant patients with Neoral® or Tacrolimus.
    Kaplan, B
    Meier-Kriesche, HU
    Minnick, P
    Bastien, MC
    Sechaud, R
    Yeh, CM
    Balez, S
    Picard, F
    Schmouder, R
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 910A - 910A
  • [6] Long-term administration of enteric-coated mycophenolate sodium in kidney transplant patients
    Salvadori, M
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 909 - 911
  • [7] Long-term safety and tolerability after conversion from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPS, myfortic) in stable maintenance renal transplant recipients
    Chapman, J
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2006, 84 (03): : A7 - A7
  • [8] The Effect of Food on Exposure to Enteric-Coated Mycophenolate Sodium (EC-MPS) in Kidney Transplant Recipients (KTR) ... Is It Clinically Significant?
    Lee, S.
    Truax, C.
    Kenyon, N.
    Raphael, K.
    Corbett, J.
    Smith, L.
    Shihab, F.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 444 - 444
  • [9] EXPOSURE TO MYCOPHENOLIC ACID ON MYCOPHENOLATE MOFETIL (MMF) AND ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) IN KIDNEY PANCREAS TRANSPLANT PATIENTS WITH SEVERE GASTROPARESIS
    Belliere, Julie
    Gandia, Peggy
    Melki, Vincent
    Duffas, Jean Pierre
    Rostaing, Lionel
    Kamar, Nassim
    Esposito, Laure
    [J]. TRANSPLANT INTERNATIONAL, 2012, 25 : 50 - 50
  • [10] MYLIFE: A PROSPECTIVE OBSERVATIONAL STUDY OF PRESCRIBING PRACTICES FOR ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) IN KIDNEY TRANSPLANT (TX) PATIENTS MANAGED
    Albano, Laetitia
    Buchler, Matthias
    Cantarovich, Diego
    Cassuto, Elisabeth
    Cointault, Olivier
    Mazouz, Hakim
    Vetromile, Fernando
    Lecuyer, Aurelie
    Tindel, Malka
    Kamar, Nassim
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 : 268 - 268
12345